IBM Watson Health and EBSCO Information Services (EBSCO) announced a strategic collaboration aimed towards enhancing clinical decision support (CDS) and operations for health care provider organizations and health systems. The companies are combining their respective solution suites – DynaMed® and IBM® Micromedex® with Watson™ – into a single, high-value global solution called “DynaMed and Micromedex with Watson.” The combined solution suite will be designed to bring together drug and disease content, into a single source for evidence-based insights to help inform clinical decisions.
DynaMed provides peer-reviewed clinical content, including systematic literature reviews in 28 specialties for comprehensive disease topics, health conditions, and abnormal findings to highly focused topics on evaluation, differential diagnosis, and management. The content undergoes a rigorous, seven-step process, giving clinicians access to current, evidence-based diagnostic and therapeutic recommendations. IBM Micromedex is one of the largest online reference databases for medication information. It is used by more than 4,500 hospitals and health systems worldwide to support decision-making in medication therapy management, disease and condition management, toxicology, alternative medicine and patient education.
IBM Micromedex with Watson is designed to use artificial intelligence and natural language processing to bypass keyword searches in favor of a more conversational approach to searching drug content. DynaMed and Micromedex with Watson will be designed to provide clinicians direct access to drug and disease content at the point-of-care to support clinical decisionmaking.
DynaMed and Micromedex with Watson is expected to be available for general adoption in April 2020. IBM Watson Health and EBSCO Information Services will also continue to sell the IBM Micromedex with Watson and DynaMed solution suites separately in order to offer flexible options to help meet customers’ needs.
IBM is an American multinational technology company headquartered in Armonk, New York, with operations in over 170 countries. IBM Watson Health is a data, analytics, and technology partner for the health industry.
EBSCO Information Services provides clinical decision support solutions, medical research information, and health care business intelligence for the health care industry. EBSCO users include professionals in medicine, nursing, and allied health.
This was reported by IBM Watson on March 11, 2020.
Contact information: Carolyn Castel, Vice President, Watson Health Communications, IBM Corporation, 1 New Orchard Road, Armonk, New York 10504; 857-337-0601; Email: firstname.lastname@example.org; Website: www.ibm.com
Contact information: Jessica Holmes, Communications Director, EBSCO Information Services, 10 Estes Street, Ipswich, Massachusetts 01938; 978-356-6500 ext. 3485; Email: email@example.com; Website: www.ebscoind.com